Chicago, Illinois-based Abbott will set up an innovation and development center in Mumbai, India aimed at developing new drug formulations, new indications, dosing, packaging and other differentiated offerings to feed into its global branded generics business that clocked sales of $3.7 billion last year. The center will act as a...
India is First To Approve Patient-Worn Glucose Sensor
Abbott, the multinational pharmaceutical and medical device company based in Illinois, has rolled out its professional version of the Flash Glucose Monitoring System in India. Priced at approximately $32, it consists of a small, round, sensor the size of a dime, which is water-resistant and disposable. This sensor is applied...